ID: ALA4294978

Max Phase: Preclinical

Molecular Formula: C19H14BrClN2O3

Molecular Weight: 433.69

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1cc(Br)cc2c1OC(N)=C(C#N)C2CC(=O)c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C19H14BrClN2O3/c1-25-17-7-11(20)6-14-13(15(9-22)19(23)26-18(14)17)8-16(24)10-2-4-12(21)5-3-10/h2-7,13H,8,23H2,1H3

Standard InChI Key:  LJIONYINPMKNCE-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 433.69

Molecular Weight (Monoisotopic): 431.9876

AlogP: 4.55

#Rotatable Bonds: 4

Polar Surface Area: 85.34

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 1.45

CX LogP: 3.99

CX LogD: 3.99

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.71

Np Likeness Score: -0.71

References

1. Pontes O, Costa M, Santos F, Sampaio-Marques B, Dias T, Ludovico P, Baltazar F, Proença F..  (2018)  Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment.,  157  [PMID:30081238] [10.1016/j.ejmech.2018.07.058]

Source

Source(1):

• Scientific Literature